The effect of NAFLD (non-alcoholic fatty liver disease) on long-term outcome of chronic hepatitis B in Iranian patients
Estakhri, A.; Sari, A.A.; Nedjat, S.N.; Rohban, M.; Rakhshani, N.; Tavangar, S.M.; Malekzadeh, R.; Montazeri, G.
Open Journal of Gastroenterology 02(01): 18-21
2012
ISSN/ISBN: 2163-9450 Accession: 088726608
Full Text Article emailed within 1 workday: $29.90
Related References
Munteanu, M.; Moussalli, J.; Rudler, M.; Lebray, P.; Perazzo, H.; Massard, J.; Pais, R.; Charlotte, F.; Thibault, V.; Olivier, L.; Hannoun, L.; Valantin, M.A.; Ngo, Y.; Drane, F.; Bismut, F.I. 2018: Long term prognostic value of the Fibro Test in patients with non-alcoholic-fatty-liver disease (Nafld), compared to chronic hepatitis C (Chc), B (Chb), and alcoholic liver disease (Ald) Journal of Hepatology 68: S99-S100Munteanu, M.; Pais, R.; Peta, V.; Deckmyn, O.; Moussalli, J.; Ngo, Y.; Rudler, M.; Lebray, P.; Charlotte, F.; Thibault, V.; Lucidarme, O.; Ngo, A.; Imbert-Bismut, F.ço.; Housset, C.; Thabut, D.; Ratziu, V.; Poynard, T. 2018: Long-term prognostic value of the FibroTest in patients with non-alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease Alimentary Pharmacology and Therapeutics 48(10): 1117-1127
Golabi, P.; Paik, J.M.; Eberly, K.; de Avila, L.; Alqahtani, S.A.; Younossi, Z.M. 2022: Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C Annals of Hepatology 27(1): 100556
Cocciolillo, S.; DiTullio, A.M.; Pagliaro, M.; Tavani, R.; di Berardino, M.; Sepe, A.; Ciccaglione, A.F.; Grossi, L.; Parruti, G.; Marzio, L. 2015: Evaluation Through Fibro Scan and Contrast Enhanced Ultrasound (Ceus) of Liver Stiffness and Liver Parenchyma Blood Flow in Non Alcoholic Fatty Liver Disease (Nafld), Chronic Hepatitis C (Chc) Without Cirrhosis vs Normal Controls Gastroenterology 148(4): S-170-S-171
Zelber-Sagi, S.; Nitzan-Kaluski, D.; Goldsmith, R.; Webb, M.; Blendis, L.; Halpern, Z.; Oren, R. 2007: Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study Journal of Hepatology 47(5): 711-717
Derakhshandeh-Rishehri, S.M.; Heidari-Beni, M.; Eftekhari, M.H. 2020: The effects of Realsil (Silybin-Phospholipid-Vitamin e Complex) on Liver Enzymes in Patients with Non-Alcoholic Fatty Liver Disease (Nafld) or Non-Alcoholic Steato-Hepatitis (Nash): a Systematic Review and Meta-Analysis of Rcts Acta Endocrinologica 16(2): 223-231
Kallman, J.; Arsalla, A.; Wheeler, A.M.; Aquino, R.D.; Terra, K.L.; Euliano, R.; Younossi, Z.M. 2008: S2079 The Impact of Hepatitis B (Hbv), Hepatitis C (Hcv) and Non-Alcoholic Fatty Liver Disease (Nafld) Guidelines On Clinical Practices Gastroenterology 134(4): A-311
Akdoğan, Öz.; Atak Yücel, A.şe.ül.; Gök Sargin, Z.; Sönmez, C.; Esendağli Yilmaz, G.ül.; Özenirler, S. 2019: Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients with Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD) as Serological Fibrosis Marker Journal of Clinical and Experimental Hepatology 9(1): 29-33
Price, J.K.; Escheik, C.; Weinstein, A.A.; Winter, P.M.; Arsalla, Z.; Gerber, L.; Younossi, Z.M. 2013: Sa1000 Medications Affecting the Autonomic Nervous System (Ans) Do Not Explain Abnormal Diastolic Blood Pressure in Patients With Chronic Hepatitis C (Ch-C) or Non-Alcoholic Fatty Liver Disease (Nafld) Gastroenterology 144(5): S-969
Canbay, A.; Bechmann, L.P.; Best, J.; Jochum, C.; Treichel, U.; Gerken, G. 2006: Crohn's disease-induced non-alcoholic fatty liver disease (NAFLD) sensitizes for severe acute hepatitis B infection and liver failure Zeitschrift für Gastroenterologie 44(3): 245-248
Tana, C.; Tana, M.; Rossi, S.; Silingardi, M.; Schiavone, C. 2016: Hepatic artery resistive index (HARI) and non-alcoholic fatty liver disease (NAFLD) fibrosis score in NAFLD patients: cut-off suggestive of non-alcoholic steatohepatitis (NASH) evolution Journal of Ultrasound 19(3): 183-189
Hachemi, M.,Benmakhlouf, S.,Prost, P.,Santolaria, N.… 2017: LaNon Alcoholic Fatty Liver Disease(NAFLD) et laNon Alcoholic Steato-Hepatitis(NASH) des pathologies de systme : revue pour le ranimateur Réanimation 26(1): 63-74
Wang, J.; Li, P.; Jiang, Z.; Yang, Q.; Mi, Y.; Liu, Y.; Shi, R.; Zhou, Y.; Wang, J.; Lu, W.; Li, S.; Liu, D. 2016: Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD Korean Journal of Internal Medicine 31(3): 479-487
Müller, P.; Messmer, M.; Bayer, M.; Pfeilschifter, J.M.; Hintermann, E.; Christen, U. 2016: Non-alcoholic fatty liver disease (NAFLD) potentiates autoimmune hepatitis in the CYP2D6 mouse model Journal of Autoimmunity 69: 51-58
Idilman, R.; Seval, G.; Çinar, K.; Mizrak, D.; Bozkuş, Y.; Arslan, M.; Bektaş, M.; Erden, E.; Özden, A. 2009: The effect of Dietary Intervention on the Long-Term Clinical Outcome of Non-Alcoholic Fatty Liver Disease Journal of Hepatology 50: S371-S372
Eder, S.K.; Feldman, A.; Strebinger, G.; Kemnitz, J.; Zandanell, S.; Niederseer, D.; Strasser, M.; Haufe, H.; Sotlar, K.; Stickel, F.; Paulweber, B.; Datz, C.; Aigner, E. 2020: Mesenchymal iron deposition is associated with adverse long-term outcome in non-alcoholic fatty liver disease Liver International: Official Journal of the International Association for the Study of the Liver 40(8): 1872-1882
Kaya, E.; Zedginidze, A.; Bechmann, L.; Canbay, A. 2022: Metabolic dysfunction-associated fatty liver disease (MAFLD) and non-alcoholic fatty liver disease (NAFLD): distinct fatty liver entities with different clinical outcomes? Hepatobiliary Surgery and Nutrition 11(2): 299-301
Brain, D.; O'Beirne, J.; Hickman, I.J.; Powell, E.E.; Valery, P.C.; Kularatna, S.; Tulleners, R.; Farrington, A.; Horsfall, L.; Barnett, A. 2020: Protocol for a randomised trial testing a community fibrosis assessment service for patients with suspected non-alcoholic fatty liver disease: LOCal assessment and triage evaluation of non-alcoholic fatty liver disease (LOCATE-NAFLD) Bmc Health Services Research 20(1): 335
Pérez-Carreras, M.; Muñoz Codoceo, C.; Ortega, M.M.; Castro, M.R.; Alfonso, F.M.; Algibez, A.M.; Gil, Y.R.; Tortajada, G.C. 2018: Temporal assessment of the non-invasive fibrosis scores Fib-4 and Non-Alcoholic Fatty Liver Disease Fibrosis Score (Nfs) in a retrospective cohort study among patients with Non-Alcoholic Fatty Liver Disease (Nafld) Journal of Hepatology 68: S565-S566
Buzzetti, E.; Hall, A.; Ekstedt, M.; Manuguerra, R.; Guerrero Misas, M.; Covelli, C.; Leandro, G.; Luong, T.; Kechagias, S.; Manesis, E.K.; Pinzani, M.; Dhillon, A.P.; Tsochatzis, E.A. 2019: Collagen proportionate area is an independent predictor of long-term outcome in patients with non-alcoholic fatty liver disease Alimentary Pharmacology and Therapeutics 49(9): 1214-1222